Dexmedetomidina como Sedativo em Crianças durante Procedimentos de Imagem

Dexmedetomidine for Sedation of Children during Imaging Procedures. Review Article

Authors

  • Thaís Arnold de Menezes HUGV/UFAM
  • Giselle Lima Afonso HUGV/UFAM
  • Juscimar Carneiro Nunes

Keywords:

Dexmedetomidine. Procedural sedation. Children. Non-Invasive Procedures.

Abstract

Children often need sedation for radiological imaging, such as magnetic resonance imaging (MRI) and computed tomography (CT), because the quality of the images depends on the immobility of the patient. Traditional sedatives (chloral hydrate, midazolam and propofol) have shown failures and adverse effects feared, such as respiratory depression. Dexmedetomidine, a potent α2-agonist, is released for use in adults only. However, the use in pediatric patients has been reported, putting it as an excellent alternative for deep sedation in Pediatrics, keeping the oxygen saturation, with minimal respiratory depression. Contrasting with clinical experience, pharmacokinetics and pharmacodynamics in children has not been fully understood yet. It may occur the decrease of the heart rate and the blood pressure but usually remain within the bounds, not requiring medical intervention. Also, initial transient hypertension may arise in a short period and with spontaneous resolution. There is still no universal protocol yet that specifies the appropriate dose according to the depth of sedation, however the main works, reviewed here, show that this drug can be used with efficacy and safety in pediatric patients

Downloads

Download data is not yet available.

References

Koroglu A, Teksan H, Sagir O, Yucel A, Toprak HI, Ersoy OM. A comparison of the sedative, hemodynamic, and respiratory effects of dexmedetomidine and propofol in children undergoing magnetic resonance imaging. Anesth Analg. 2006; 103: 63-7.

Ahmed SS, Unland T, Slaven JE, Nitu ME. High Dose Dexmedetomidine: Effective as a Sole Agent Sedation for Children Undergoing MRI. International Journal of Pediatrics. 2015; 397372. doi:10.1155/2015/397372.

Bartolomé SM, Cid JL, Freddi N. Sedação e analgesia em crianças: uma abordagem prática para as situações mais freqüentes. J. Pediatr. 2007; 83: 71-S82.

Mahmoud M, Manson K. Dexmedetomidine: review, update, and future considerations of paediatric perioperative and periprocedural applications and limitations. Br J Anaesth. 2015; 115(2): 171-82.

Phan H, Nahata, MC. Clinical Uses of Dexmedetomidine in Pediatric Patients. Pediatr Drugs. 2008; 10(1): 49-69.

Tobias, Joseph D. Clinical uses of dexmedetomidine in pediatric anesthesiology and critical care. Seminars in Anesthesia, Perioperative Medicine and Pain. 2006; 25(2): 57-64.

Manson KP, Lerman J. Dexmedetomidine in Children: Current Knowledge and Future Applications. Anesth Analg. 2011; 113(5): 1129-1142.

Gertler R, Brown HC, Mitchell DH, Silvius EN. Dexmedetomidine: a novel sedative analgesic agent. Proceedings (Baylor University Medical Center). 2001; 14(1): 13-21.

Nelson LE, Lu J, Guo T, Saper CB, Franks NP, Maze M. The α2-adrenoceptor agonist dexmedetomidine converges on an endogenous sleep-promoting pathway to exert its sedative effects. Anesthesiology. 2003; 98: 428-36.

Cangiani LM, Slullitel A, Potério GMB, Pires OC, Posso IP, Nogueira CS. Tratado de Anestesiologia – SAESP. 7a ed. São Paulo: Atheneu; 2011. 401-15.

Riker RR, Fraser GL. Adverse events associated with sedatives, analgesics, and other drugs that provide patient comfort in the intensive care unit. Pharmacotherapy. 2005; 25(5): 8S-18S.

Buck ML. Dexmedetomidine Use in Pediatric Intensive Care and Procedural Sedation. The Journal of Pediatric Pharmacology and Therapeutics: JPPT. 2010; 15(1): 17-29. 13. Khan ZP, Ferguson CN, Jones RM. Alpha-2 and imidazoline receptor agonists - Their pharmacology and therapeutic role. Anaesthesia. 1999; 54(2): 146-65.

Szmuk P, Steiner JW, Sheeran PW, Farrow-Gillespie AC, Ezri T. Sedation and anesthesia for magnetic resonance imaging in pediatric patients: is dexmedetomidine the answer?. Seminars in Anesthesia, Perioperative Medicine and Pain. 2007; 26(4): 229-36.

Petroz GC, Sikich N, James M, van Dyk H, Shafer SL, Schily M et al. A phase I, two center study of the pharmacokinetics and pharmacodynamics of dexmedetomidine in children. Anesthesiology. 2006; 105: 1098-110.

Published

2021-10-19

Issue

Section

Revisão de Literatura